Speranza Therapeutics announces value-based program for opioid detox facilities program vows to reduce costly facility against Medical Advice (AMA) leave rates
August 4, 2021
August 4, 2021
June 10, 2021
March 23, 2021
January 6, 2021
December 17, 2020
December 15, 2020
September 17, 2020
September 17, 2020
June 16, 2020
December 16, 2024
BetaGlue® Therapeutics S.p.A. (“BetaGlue”) an Italian clinical-stage oncology company developing an innovative radiotherapy platform for the targeted ...
December 11, 2024
The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to...
December 10, 2024
Innovative Cell Expansion System Enables Real-Time Metabolic Monitoring and Automated Culture Optimization to Accelerate Cell and Gene Therapy Manufac...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225